Back pain is a problem that many people experience, especially as they age. One common cause is a condition called ...

It’s clear that CrossFit provides a range of benefits, and recently, researchers set out to explore if it could also reduce ...

Researchers at the NYU Pain Research Center have identified a novel receptor for nerve growth factor (NGF) that plays a critical role in pain signaling, despite being unable to signal independently.

Vertex Pharmaceuticals Inc.’s non-addictive drug helped patients with lower back pain, moving the company closer to selling ...

Scientists are now using artificial intelligence (AI) for drug discovery in advanced ... Oct. 2, 2024 — A new study showed that reducing daily sitting prevented back pain from worsening over six ...

Both misunderstood and mismanaged, low back pain is a huge source of suffering for many people worldwide. Here's the ...

s nonaddictive drug for lower back pain didn’t do better than ... If approved, Vertex’s drug would be the first new class of pain medication in more than two decades.

but new ones often develop. Up to 70% of women will develop at least one fibroid before menopause. Factors that increase the risk of developing fibroids include: Uterine fibroids can cause symptoms ...

Professor Gamper's research, published in the Journal of Clinical Investigation (JCI) in June 2024, paves the way for the creation of new, targeted medications that could block pain signals ...